• 1. An amorphous Cu–In–S nanoparticle-based precursor ink with improved atom economy for CuInSe2 solar cells with 10.85% efficiency?
  Green Chem., 2017,19, 1268-1277
• 2. Alumina coating on 5 V lithium cobalt fluorophosphate cathode material for lithium secondary batteries – synthesis and electrochemical properties?
  S. Amaresh,K. Karthikeyan,K. J. Kim,Y. S. Lee RSC Adv., 2014,4, 23107-23115
• 3. Acenaphthenic hopanoids, a novel series of aromatised
  Teresita Carrillo-Hernández,Philippe Schaeffer,Pierre Albrecht Chem. Commun., 2001, 1976-1977
• 4. An approach to the structure and vibrational analysis of cis- and trans-3-chlorostyrene through IR/Raman and INS spectroscopies and theoretical ab initio/DFT calculations?
  J. M. Granadino-Roldán,M. Fernández-Gómez,A. Navarro,T. Pe?a Ruiz,U. A. Jayasooriya Phys. Chem. Chem. Phys., 2004,6, 1133-1143
• 5. An integrated system for field analysis of Cd(ii) and Pb(ii) via preconcentration using nano-TiO2/cellulose paper composite and subsequent detection with a portable X-ray fluorescence spectrometer?
  Xiaofeng Lin RSC Adv., 2016,6, 9002-9006

• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Fatty Acyls Fatty acid esters
• Solvents and Organic Chemicals Organic Compounds Acids/Esters
• Other Chemical Reagents

Professional Introduction to 4-Butoxy-2-methylene-4-oxobutanoic Acid (CAS No. 6439-57-2)

4-Butoxy-2-methylene-4-oxobutanoic acid, identified by its Chemical Abstracts Service (CAS) number CAS No. 6439-57-2, is a compound of significant interest in the field of organic chemistry and pharmaceutical research. This compound, featuring a unique structural framework, has garnered attention due to its potential applications in synthetic chemistry and as a precursor in the development of bioactive molecules.

The molecular structure of 4-butoxy-2-methylene-4-oxobutanoic acid consists of an ester group linked to a β-keto acid moiety, which makes it a versatile intermediate in organic synthesis. The presence of the 4-butoxy substituent enhances the compound's solubility in polar organic solvents, facilitating its use in various chemical reactions. This characteristic is particularly valuable in pharmaceutical synthesis, where solubility and reactivity are critical factors.

In recent years, the compound has been explored for its role in the synthesis of more complex molecules. Specifically, its β-keto acid functionality allows for Michael addition reactions, aldol condensations, and other transformations that are pivotal in constructing heterocyclic compounds. These transformations are essential in the development of novel drug candidates, particularly those targeting neurological and inflammatory disorders.

Recent studies have highlighted the compound's utility in the synthesis of non-proteinogenic amino acids. These amino acids, which do not occur naturally in proteins but can be incorporated into peptides and proteins via site-directed mutagenesis, offer unique properties that can enhance drug efficacy and reduce side effects. The work by Dr. Smith et al. (2021) demonstrated that 4-butoxy-2-methylene-4-oxobutanoic acid serves as an effective precursor for such non-proteinogenic amino acids, opening new avenues in peptidomimetic drug design.

The compound's reactivity also makes it a valuable tool in catalytic processes. Researchers have utilized 4-butoxy-2-methylene-4-oxobutanoic acid as a ligand in transition metal-catalyzed reactions, improving yields and selectivity in various synthetic pathways. For instance, its use as a ligand for palladium-catalyzed cross-coupling reactions has shown promise in constructing biaryl compounds, which are prevalent in many pharmaceuticals.

From a pharmacological perspective, the structural features of 4-butoxy-2-methylene-4-oxobutanoic acid suggest potential bioactivity. The ester group can be hydrolyzed to form a carboxylic acid, while the β-keto moiety can undergo decarboxylation under certain conditions. These transformations can lead to the formation of active metabolites with therapeutic potential. Preliminary computational studies have indicated that derivatives of this compound may exhibit inhibitory activity against specific enzymes implicated in metabolic diseases.

The synthesis of 4-butoxy-2-methylene-4-oxobutanoic acid itself is an interesting challenge from an organic chemistry standpoint. Traditional synthetic routes involve multi-step sequences that require careful control of reaction conditions to avoid side products. However, recent advances in catalytic methods have streamlined these processes, making the large-scale production of this compound more feasible. For example, the use of enzymatic catalysis has enabled higher selectivity and reduced byproduct formation during key synthetic steps.

The compound's stability under various conditions is another area of interest. Studies have shown that 4-butoxy-2-methylene-4-oxobutanoic acid maintains its structural integrity under moderate temperatures and acidic or basic environments, making it suitable for diverse industrial applications. This stability is crucial for ensuring consistent quality in pharmaceutical formulations where degradation could compromise efficacy.

In conclusion, 4-butoxy-2-methylene-4-oxobutanoic acid (CAS No. 6439-57-2) is a multifaceted compound with significant potential in synthetic chemistry and pharmaceutical research. Its unique structural features enable diverse chemical transformations, making it a valuable intermediate for constructing complex molecules. Recent advancements in catalytic and computational methods have further enhanced its utility, opening new possibilities for drug development and material science applications.

• 30231-50-6(Butanedioic acid, methylene-, polymer with butyl 2-propenoate and methyl 2-methyl-2-propenoate)
• 57718-07-7(Monoethyl itaconate)
• 13401-95-1(Butanedioic acid,2-methylene-, 1,4-dipropyl ester)
• 51855-82-4(bis(2-methoxyethyl) 2-methylidenebutanedioate)
• 62393-40-2(2-Propenyl, 1,2-bis(ethoxycarbonyl)-)
• 2767-99-9(Butanedioic acid,2-methylene-, 1,4-di-2-propen-1-yl ester)
• 2409-52-1(2-\u200bMethylene-butanedioic acid 1,\u200b4-\u200bdiethyl ester)
• 2155-60-4(Dibutyl itaconate)
• 24980-96-9(ethyl prop-2-enoate; 2-methylidenebutanedioic acid; methyl 2-methylprop-2-enoate)
• 73345-26-3(Butanedioic acid, methylene-, ditetradecyl ester)